Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael...

[HTML] sciencedirect.com

[HTML][HTML] Improving gastrointestinal cancer therapy by uniting stakeholders

M Quante, A Saborowski, CB Westphalen - ESMO Gastrointestinal …, 2024 - Elsevier
Highlights•Gastrointestinal cancer belongs to challenging malignancies with low survival
rates.•Precision oncology using molecular diagnostics is crucial for patient …
相关文章 所有 3 个版本